Research Article
Prevalence and Management of Transfusional Iron Overload in Syrian Beta Thalassemia Major Patients Pre and during the Syrian Conflict
Table 1
Comparison of the patients’ demographic and clinical characteristics between the 2009 (preconflict) and 2019 (during conflict) cohorts.
| Characteristics | 2009 (preconflict) cohort () | 2019 (during conflict) cohort () | value |
| Age (years) | | Median (Range) | 14 (3-32) | 10 (3-34) | <0.0001 | Sex, (%) | | Males | 102 (49.76%) | 87 (50.58%) | 0.8732 | Females | 103 (50.24%) | 85 (49.42%) | Number of blood units transfused per month | 2-3 units | 2-3 units | | Hb prior to blood transfusion Median (g/dL) (Range) | 8.7 (7.2-9.5) | 8.1 (6.7-9.9) | <0.0001 | Iron chelation regimen, (%) Age (years), Median (Range) | DFO | 81 (39%) | 28 (16.3%) | 0.0085 | 13 (4-29) | 16 (3-32) | DFP | 20 (10%) | 47 (26.3%) | 0.0034 | 9 (7-10) | 12 (4-34) | DFO+DFP | 43 (21%) | 50 (29.1%) | 0.671 | 15 (10-32) | 15 (3-29) | DFX | 61 (30%) | 21 (12.2) | 0.1341 | 7 (3-19) | 6 (3-11) | No ICT for six years (2012-2018) | 0 (0%) | 26 (15.1%) | — | 15 (9-29) |
|
|
was considered statistically significant. |